CLPT May 2024 5.000 call
| Previous close | 1.1000 |
| Open | 1.4500 |
| Bid | 0.0000 |
| Ask | 1.4000 |
| Strike | 5.00 |
| Expiry date | 2024-05-17 |
| Day's range | 1.4500 - 1.4500 |
| Contract range | N/A |
| Volume | |
| Open interest | 30 |
- GuruFocus.com
ClearPoint Neuro Inc (CLPT) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue Growth ...
ClearPoint Neuro showcases a 41% revenue increase and strategic expansions in biologics and capital equipment sectors.
GlobeNewswireClearPoint Neuro Reports First Quarter 2024 Results
First Quarter Revenue Growth +41%; Record Revenue AchievedSOLANA BEACH, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced financial results for its first quarter ended March 31, 2024. First Quarter Highlights Reported quarterly revenue of $7.6 million, a 41% year-over-year increase;Increased biologics and drug delivery revenue
- GlobeNewswire
ClearPoint Neuro to Present Novel Research and Exhibit at the 27th American Society of Gene & Cell Therapy Annual Meeting in Baltimore
SOLANA BEACH, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced it will present novel research and exhibit at the 27th American Society of Gene & Cell Therapy Annual Meeting to be held in Baltimore, MD from May 7-11. The following original research abstracts will be presented at the Poster Session: De-Risking Clinical Trials Le
